About
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $350 million under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises over 40 companies that develop breakthrough solutions to substantial unmet needs. Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing managements to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.
Sector Focus
Healthcare
Drug Development
Genomics
Next Generation Sequencing
Biotech
Oncology
Clinical
Analytics
Diabetes Risk
Retail
Series Focus
Series A
Series B
Series C
Cheque Size
$2.0M - $200.0M
Score Breakdown
56Deal Activity
58Track Record
48Visibility
7Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Pontifax?
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $350 million under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises over 40 companies that develop breakthrough solutions to substantial unmet needs. Pontifax invests in breakthrough innovation regardless of therapeutic area or development…
What kind of firm is Pontifax?
Pontifax is a Venture Capital.
What is Pontifax's assets under management?
Pontifax manages approximately $620M in assets.
Where is Pontifax based?
Pontifax is based in Israel.
What sectors does Pontifax focus on?
Pontifax focuses on Healthcare, Drug Development, Genomics, Next Generation Sequencing.
Similar Investors